» Articles » PMID: 2161898

Properties of Monocyte Chemotactic and Activating Factor (MCAF) Purified from a Human Fibrosarcoma Cell Line

Overview
Journal J Exp Med
Date 1990 Jun 1
PMID 2161898
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

A monocyte chemotactic and activating factor (MCAF) has been purified from TNF-stimulated 8387 human fibrosarcoma cell line-conditioned media. The purified MCAF showed microheterogeneity yielding two bands on SDS-PAGE analysis. Fibrosarcoma-derived MCAF specifically competed with THP-1 (a human monocytic cell line)-derived 125I-labeled MCAF in binding to human PBMC, whereas a similar basic heparin-binding leukocyte chemoattractant, IL-8, did not. The purified MCAF stimulated superoxide anion and N-acetyl beta-D glucosaminidase-releasing activity in human monocytes, as well as monocyte cytostatic augmenting activity against tumor cells and chemotactic activity for monocytes. When injected subcutaneously into Lewis rat ears, the purified human MCAF also induced considerable in vivo local monocyte infiltration beginning at 3 h and becoming maximal at 18 h. In conclusion, the data presented in this paper indicate that MCAF is a potent activator of monocytes as well as a monocyte recruitment factor that acts through receptors that are specific for this novel molecule. This novel cytokine might have an important role in tumor growth control due to its ability to attract and activate monocytes.

Citing Articles

The cutaneous beta human papillomavirus type 8 E6 protein induces CCL2 through the CEBPα/miR-203/p63 pathway to support an inflammatory microenvironment in epidermodysplasia verruciformis skin lesions.

Vella L, Sternjakob A, Lohse S, Fingerle A, Sperling T, Wickenhauser C Front Cell Infect Microbiol. 2024; 14:1336492.

PMID: 38510961 PMC: 10953690. DOI: 10.3389/fcimb.2024.1336492.


The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis.

Yoshimura T, Li C, Wang Y, Matsukawa A Cell Mol Immunol. 2023; 20(7):714-738.

PMID: 37208442 PMC: 10310763. DOI: 10.1038/s41423-023-01013-0.


Putrescine supplementation shifts macrophage L-arginine metabolism related-genes reducing Leishmania amazonensis infection.

Zanatta J, Acuna S, de Souza Angelo Y, de Almeida Bento C, Peron J, Stolf B PLoS One. 2023; 18(3):e0283696.

PMID: 37000792 PMC: 10065296. DOI: 10.1371/journal.pone.0283696.


Nanotherapy: New Approach for Impeding Hepatic Cancer Microenvironment via Targeting Multiple Molecular Pathways.

Abd-Rabou A, Ahmed H, Mohamed S, Kotob S, Kishta M Asian Pac J Cancer Prev. 2022; 23(12):4261-4274.

PMID: 36580009 PMC: 9971455. DOI: 10.31557/APJCP.2022.23.12.4261.


Molecular mechanism of gossypol mediating CCL2 and IL‑8 attenuation in triple‑negative breast cancer cells.

Messeha S, Zarmouh N, Mendonca P, Cotton C, Soliman K Mol Med Rep. 2020; 22(2):1213-1226.

PMID: 32627003 PMC: 7339712. DOI: 10.3892/mmr.2020.11240.


References
1.
Pick E, Mizel D . Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J Immunol Methods. 1981; 46(2):211-26. DOI: 10.1016/0022-1759(81)90138-1. View

2.
Matsushima K, Akahoshi T, Yamada M, Furutani Y, Oppenheim J . Properties of a specific interleukin 1 (IL 1) receptor on human Epstein Barr virus-transformed B lymphocytes: identity of the receptor for IL 1-alpha and IL 1-beta. J Immunol. 1986; 136(12):4496-502. View

3.
Wang J, Cianciolo G, Snyderman R, Mantovani A . Coexistence of a chemotactic factor and a retroviral P15E-related chemotaxis inhibitor in human tumor cell culture supernatants. J Immunol. 1986; 137(8):2726-32. View

4.
Furuta R, Yamagishi J, Kotani H, Sakamoto F, Fukui T, Matsui Y . Production and characterization of recombinant human neutrophil chemotactic factor. J Biochem. 1989; 106(3):436-41. DOI: 10.1093/oxfordjournals.jbchem.a122870. View

5.
Matsushima K, Larsen C, DuBois G, Oppenheim J . Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med. 1989; 169(4):1485-90. PMC: 2189236. DOI: 10.1084/jem.169.4.1485. View